Animal, in vitro and computational models for preclinical analysis of cell-based cancer therapies
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: National Center for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)
19 November 2018
|Description:||The NC3Rs and the Cell and Gene Therapy Catapult hosted a one day workshop to explore preclinical testing of cell-based therapies for cancer.|
Optional / Voluntary
Professionals (e.g. veterinarians), Scientific officers / Project managers, Managers, Technicians, Teachers and educators, Regulators and policy-makers, Researchers
SMEs, Consulting, Contract Research Organizations (CROs), Governmental bodies, Industry, Academia
Continuing Professional Development
In vitro methods, Computational methods
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
The workshop will focus on:
Cover the current best practice in developing cell-based therapies,
The benefits and limitations of using animal and non-animal models,
How translation can be enabled by the application of in vitro and computational methods
Funding opportunities in preclinical modelling of cell-based therapies.
Directive 2010/63/EU or equivalent
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.